Articles from Inspection Monitor (October 1, 2007)

Title	Author	Type	Words
8-item 483 handed to blood bank for poor identification of test samples.			629
After 6-year gap, sites to be inspected yearly: FDAer.			491
ChemAgis written up for stability sampling completed late.			374
Dialysis Services slapped with 6-item 483 for faulty design procedures.			400
Draft guidance on GMPs for Phase I INDs to clear in late 2007, says senior compliance officer.			540
Inspection log.			240
Parkedale clears pre-approval inspection; validation, media fill time issues noted.			2153
Risk-based auditing nets 6% decrease in follow up FDA audits in same year.			550